- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02352961
An Implementation Science Study Investigating Profiles of Men Interested in MMC (Imbizo)
An Implementation Science Study Investigating Profiles of Men Interested in Medical Male Circumcision (MMC), Barriers and Methods to Increase the Uptake of MMC Among Older Men in South Africa
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Part I (Formative Period) Given these issues, in addition to establishing a baseline estimate of the ages and risk behaviours of males currently undergoing MMC at the Aurum clinic over a six month period, we include a qualitative research component. We conducted research in 2014 to establish a baseline estimate of the ages and risk behaviours of males undergoing MMC at the Aurum clinic over a six month period. The baseline estimate (Ethics reference number M130711) will be referred to as the formative Part I. The formative Part I includes a quantitative and qualitative research component. The qualitative component will include both genders and be used to develop MMC recruitment messaging tailored to mature men(25-49 years old) . Men will provide their opinion on circumcision and on what type of marketing message they feel will encourage mature men (25-49 years old) to be circumcised. Women will also provide their perspectives on male circumcision and what messaging could be used to encourage their partners or male family members to be circumcised. During this study, we explored if women have a role in promoting male circumcision to their partners, family and the community. These qualitative findings will be used to develop interventions to increase the ratio of men (25-49 years old) mature, or at least of higher risk men, undergoing MMC at the clinic. These interventions and the outcomes related to them will be presented as an amendment to this protocol after the baseline and qualitative data are collected and analysed.
Part II (Intervention Period) Findings from the formative period will be used to develop interventions to increase the ratio of men (25-49 years)mature, or at least of higher risk men, undergoing MMC at the clinic. During this proposed intervention period we would like to evaluate the effectiveness of those interventions and the outcomes related to them. These proposed interventions will directly address the barriers to MMC that challenge uptake of MMC among mature men (25-49 years). Additionally, epidemiologic research will be conducted among men attending our MMC clinic to evaluate whether mature men (25-49 years) exhibit, as is presumed, higher risk profiles for HIV. We will also explore the cost-effectiveness of this strategy.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Gauteng, South Africa, 1632
- The Aurum Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Males 18 and above accessing medical male circumcision services in Ekurhuleni North, South Africa
Females 18 and above who live in the vicinity of Ekurhuleni North, South Africa
Description
Inclusion Criteria for Cross Sectional Component Inclusion Criteria:
All males who meet the following criteria will be eligible for inclusion:
- Are aged 18 years or older (no upper age limit)
- Have never been completely medically circumcised (as opposed to partial circumcision)
- Willing and able to give their written informed consent so that the information collected during the clinic visit can be analysed for research purposes.
Inclusion Criteria Qualitative Component for males
All males who meet the following criteria will be eligible for inclusion:
- Present at Aurum's male circumcision clinic during the cross sectional component or men who indicate no interest in medical male circumcision
- Are between the ages of 25 and 49 inclusive
- Are not circumcised at the time of the interview as assessed through visual examination
- Is willing and able to provide written informed consent.
- Willing for the qualitative session to be tape recorded
Inclusion Criteria for Qualitative Component for females Women who meet the following criteria will be eligible for inclusion
- Are 18 and above (no upper age limit)
- Has a partner who is participating in the cross sectional component, is not in a relationship but lives in the vicinity of Ekurhuleni North district or is part of a women's organization within the community where the clinic is located
- Is willing and able to provide written informed consent
- Willing for the qualitative session to be tape recorded
Inclusion Criteria Part II (Intervention Period) Inclusion Criteria for the "Exclusive Intervention Strategy" Men who meet the following criteria will be eligible for inclusion in the intervention period
- Are between the ages 25 and 49 years inclusive
- Has never been medically circumcised
- Is willing and able to provide written informed consent
Inclusion Criteria for the "Active Follow-up Intervention" Men who meet the following criteria will be eligible for inclusion
- Are between the ages 25 and 49 years inclusive
- Has never been medically circumcised
- Is willing and able to provide written informed consent
- Has contra-indication/s to MMC on the day of presentation for MMC
- Is willing to provide contact information for retention
Exclusion Criteria for all Aims:
- Men who are unable to communicate sufficiently (in English or local languages) to complete medical forms and/or research questionnaires for the cross sectional component.
- Men and women who do not in the opinion of staff obtaining consent have the capacity to provide written informed consent will be excluded from the research.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Current proportion of mature men (25-49 years) presenting for and undergoing MMC
Time Frame: 6 months
|
To describe the current proportion of mature men (25-49 years) presenting for and undergoing MMC compared to all men (18 and above) during a 6 month period when routine service delivery and outreach messaging will be employed at one Aurum site.
|
6 months
|
Particular barriers to MMC among men (25-49 years)
Time Frame: 6 months
|
To describe the particular barriers to MMC among men (25-49 years) regardless of circumcision status, develop tailored messaging and outreach materials promoting MMC to mature men.
|
6 months
|
Barriers to MMC and using the perspective of women
Time Frame: 6 months
|
To investigate the particular barriers to MMC and using the perspective of women develop tailored messaging and outreach materials promoting MMC to mature men.
|
6 months
|
Effectiveness of offering an "Exclusive Intervention Strategy"
Time Frame: 6 months
|
Evaluate the effectiveness of offering an "Exclusive Intervention Strategy" comprised of customized services to mature (25-49 years) men.
To achieve this aim we will compare the proportion of mature men (25-49 years) presenting for MMC during the formative and intervention periods.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Risk behaviours
Time Frame: 6 months
|
Identify risk behaviours (e.g.
multiple partners; inconsistent condom use and STI symptoms) of men currently presenting at the Aurum MMC clinic.
|
6 months
|
Compare risk behaviours to national prevalence
Time Frame: 6 months
|
Compare risk behaviours of men presenting for MMC with that of national prevalence estimates of risk behaviour.
|
6 months
|
Risk profile, age and source of recruitment
Time Frame: 6 months
|
Describe the risk profile, age and sources of recruitment of men presenting at the clinic.
To achieve this aim we will examine each of these factors over time.
|
6 months
|
Factors associated with the intervention
Time Frame: 6 months
|
Identify whether the intervention is associated with HIV risk behaviours (for example multiple partners), having adjusted for age.
This is to identify if the intervention has resulted in men attending for MMC with a different risk profile over and above any anticipated age differences.
|
6 months
|
Socio-demographic factors
Time Frame: 6 months
|
Identify socio-demographic factors associated with HIV risk behaviours, among mature men (25-49 years).
|
6 months
|
Effectiveness of active follow-up
Time Frame: 6 months
|
Evaluate the effectiveness of an active follow-up system on completion of MMC among mature men (25-49 years) who present for MMC but who are initially referred for care due to contra-indication to MMC
|
6 months
|
Cost effectiveness
Time Frame: 6 months
|
To determine the cost-effectiveness of this intervention among mature men (25-49 years).
|
6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Salome Charalambous, MBBCH, PhD, Aurum Institute
Publications and helpful links
General Publications
- Chetty-Makkan CM, Grund JM, Muchiri E, Price MA, Latka MH, Charalambous S. High risk sexual behaviours associated with traditional beliefs about gender roles among men interested in medical male circumcision in South Africa. AIDS Res Ther. 2021 Jun 22;18(1):33. doi: 10.1186/s12981-021-00359-7.
- Grund JM, Chetty-Makkan CM, Ginindza S, Munyai R, Kisbey-Green H, Maraisane M, Charalambous S. Effectiveness of an "Exclusive Intervention Strategy" to increase medical male circumcision uptake among men aged 25-49 years in South Africa. BMC Public Health. 2018 Jul 13;18(1):868. doi: 10.1186/s12889-018-5729-6.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- AUR2-4-121
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medical Male Circumcision
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
University of Alabama at BirminghamCentre for Infectious Disease Research in ZambiaRecruitingVoluntary Medical Male CircumcisionZambia
-
University of WashingtonNational Institute of Nursing Research (NINR); Aurum InstituteCompletedVoluntary Medical Male CircumcisionSouth Africa
-
University of WashingtonUniversity of Zimbabwe; Medic Mobile; International Training and Education Center... and other collaboratorsCompletedVoluntary Medical Male CircumcisionZimbabwe
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Medical University of South CarolinaCompleted
-
Simunye Primary Health CareCompleted
Clinical Trials on Exclusive Intervention Strategy
-
University Hospital, AngersRecruitingPhysical Activity | AgedFrance
-
Region ÖstergötlandLinkoeping University; Örebro University, SwedenActive, not recruitingOccupational HealthSweden
-
Indiana UniversityCompletedCorrect Consistent Condom UseUnited States
-
Goethe UniversityMaastricht University Medical Center; German Federal Ministry of Education... and other collaboratorsCompleted
-
Columbia UniversityNational Institute on Aging (NIA)RecruitingHealthy AgingUnited States
-
Jiangsu Taizhou People's HospitalRecruitingEnd Stage Renal Disease on DialysisChina
-
George Washington UniversityActive, not recruitingPrEP | HIV Risk PerceptionUnited States
-
European Institute of OncologyRecruiting
-
University Health Network, TorontoCanadian Initiative for Outcomes in Rheumatology CareRecruiting
-
Guangzhou Institute of Respiratory DiseaseCompleted